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The midbody interactome reveals unexpected roles
for PP1 phosphatases in cytokinesis
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The midbody is an organelle assembled at the intercellular bridge between the two daughter
cells at the end of mitosis. It controls the final separation of the daughter cells and has been
involved in cell fate, polarity, tissue organization, and cilium and lumen formation. Here, we
report the characterization of the intricate midbody protein-protein interaction network
(interactome), which identifies many previously unknown interactions and provides an
extremely valuable resource for dissecting the multiple roles of the midbody. Initial analysis of
this interactome revealed that PP1β-MYPT1 phosphatase regulates microtubule dynamics in
late cytokinesis and de-phosphorylates the kinesin component MKLP1/KIF23 of the cen-
tralspindlin complex. This de-phosphorylation antagonizes Aurora B kinase to modify the
functions and interactions of centralspindlin in late cytokinesis. Our findings expand
the repertoire of PP1 functions during mitosis and indicate that spatiotemporal changes in the
distribution of kinases and counteracting phosphatases finely tune the activity of cytokinesis
proteins.
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Growth, development, and reproduction in multicellularorganisms depend on the faithful segregation of genomicand cytoplasmic material that occurs during cell division.
Errors during this process are responsible for many human dis-
eases, including cancer. In the final step of cell division, the
mother cell divides into two daughter cells during the process of
cytokinesis. This major cell shape change requires the assembly
and coordinated activity of two cytoskeletal structures: the acto-
myosin contractile ring, which assembles at the equatorial cortex
and drives the ingression of the cleavage furrow; and the central
spindle, an array of anti-parallel and interdigitating microtubules,
which is essential for positioning the cleavage furrow, keeping the
dividing genomes apart, and for the final separation, i.e., abscis-
sion, of the daughter cells1. The contractile ring and the central
spindle are composed of several proteins and protein complexes
that act as structural and regulatory factors that control the for-
mation, dynamics and stability of these cytoskeletal structures
throughout cytokinesis1,2. Like in many other processes during
cell division, the functions and interactions of these proteins are
often regulated by reversible posttranslational modifications,
including phosphorylation/dephosphorylation mostly mediated
by serine/threonine kinases and their counteracting phospha-
tases3. During furrow ingression, the contractile ring compacts
the central spindle and, after completion of furrow ingression, the
two daughter cells remain connected by an intercellular bridge,
which contains at its center an organelle, the midbody, composed
of a multitude of proteins that have diverse functions. Some
midbody proteins are former components of the contractile ring
and central spindle, while others are specifically recruited during
the slow midbody maturation process that ultimately leads to the
abscission of the two daughter cells4,5. All these proteins are
arranged in a very precise and stereotyped spatial pattern along
the midbody6, which can be divided in approximately three major
regions: the midbody ring, containing mostly former contractile
ring components like Anillin and Citron kinase; the midbody
central core marked by central spindle proteins such as the
centralspindlin complex; and the midbody arms that flank the
midbody core and where the chromosomal passenger complex
(CPC) and the kinesin KIF20A accumulate4. The proper locali-
zation, regulation and interactions of all these proteins are
essential for the execution of abscission and for preventing
incorrect genome segregation5. Furthermore, recent evidence
indicates that the midbody is also involved in many other pro-
cesses besides cell division, including cell fate, pluripotency,
apical-basal polarity, tissue organization, and cilium and lumen
formation7,8. Therefore, the characterization of the intricate
midbody protein interaction networks (i.e., interactome) and
their regulation is essential for understanding how this organelle
executes its multiple functions.
In this study, we report the characterization of the midbody
interactome identified by affinity purifications coupled with mass
spectrometry (AP-MS) of ten key midbody components. This
valuable resource provides a molecular blueprint of the intricate
connections amongst midbody components that will be pivotal in
dissecting the multiple functions of this organelle. In support of
this, our initial analysis of the midbody interactome already
revealed a plethora of previously unidentified interactions and
highlighted a role of the PP1β-MYPT1 phosphatase in regulating
the dynamics of central spindle microtubules by antagonizing
Aurora B phosphorylation of the centralspindlin component
MKLP1 in late cytokinesis.
Results
CIT-K interactions increase specifically during cytokinesis.
Citron kinase (CIT-K) is a contractile ring component that acts
as a major midbody organizer by interacting with several mid-
body components, including the CPC and centralspindlin,
and by maintaining their correct localization and orderly
arrangement9,10. As a first step toward the characterization of the
midbody interactome, we used a human HeLa cell line stably
expressing CIT-K tagged with GFP11 to identify the CIT-K
interactomes at different cell cycle stages—S phase, metaphase,
and telophase—by AP-MS (Fig. 1a, b and Supplementary Data 1).
We found that the number of CIT-K interactors consistently
increased in telophase in three separate replicates, confirming the
important role of this kinase in cytokinesis (Fig. 1b). Notably,
only 62 proteins, including the bait CIT-K and two of its known
partners, the contractile ring component Anillin and the kinesin
KIF1412,13, were common to all three mitotic stages (Fig. 1b and
Supplementary Data 1), indicating that our AP-MS methodology
identifies specific interactions and generates little noise.
To assess whether CIT-K was required for recruiting some of
these interactors to the midbody, we used SILAC-based
quantitative MS to characterize and compare the proteomes of
midbodies purified from telophase HeLa cells treated with either
CIT-K or control siRNAs (Fig. 1c, Supplementary Fig. 1, and
Supplementary Data 2). Only minor differences in the levels of a
few midbody proteins were identified, including Filamin B, the
kinesin KIFC1, Aurora A kinase and its interactor TPX2 (Fig. 1d,
Supplementary Table 1 and Supplementary Data 2). Although
some of these differences were significant and validated by
western blot (Fig. 1e and Supplementary Table 1), overall our
results did not indicate a major role for CIT-K in recruiting
midbody proteins and reinforced the evidence that CIT-K has a
very specific function in the organization of this organelle.
Finally, it is important to point out that our midbody proteome
contains a significant higher number of proteins than a previous
study14. This most likely reflects the considerable advancements
in MS technology in recent years rather than a difference in the
midbody purification protocols.
The midbody interactome has common and specific networks.
To further our knowledge of the interaction networks within the
midbody, we expanded our AP-MS experiments to include nine
additional baits, all proteins that are well known to play key roles
in midbody assembly and cytokinesis and display specific and
distinct localization patterns (Table 1). AP-MS analysis of the
interactions of these ten baits in telophase revealed a complex
midbody interactome comprising almost 3000 proteins (Supple-
mentary Data 3, 4), which included the majority of midbody
proteome components and showed a Gene Ontology (GO)
enrichment profile very similar to the midbody proteome char-
acterized in our SILAC experiments (Fig. 2 and Supplementary
Data 4, 5). The overlap and similarity between the two datasets is
highly significant considering that they were obtained using two
completely different experimental procedures (see Methods). The
midbody interactome contains complex networks shared by
several baits as well as networks specific for each bait or for just a
few baits (Fig. 3a–d). Interestingly, even proteins strictly related,
like the two ESCRT-III paralogs CHMP4B and CHMP4C,
showed distinct specific networks (Fig. 3a). Analysis of the
interactome networks further confirmed the specificity and
selectivity of our AP-MS methodology. For example, the con-
tractile ring component Anillin presents a specific interaction
network that includes the vast majority of septin proteins
(Fig. 3b), which are known to be recruited by Anillin to
midbody15,16. Similarly, the mitotic kinase Polo-like kinase 1
(Plk1) was only identified with the bait PRC1 (Fig. 3d), which
directly binds to and recruits Plk1 to the central spindle and
midbody in both human and Drosophila cells17,18.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12507-9
2 NATURE COMMUNICATIONS |         (2019) 10:4513 | https://doi.org/10.1038/s41467-019-12507-9 | www.nature.com/naturecommunications
Our midbody interactome revealed a plethora of interactions
that can lead to the discovery of important structural and
regulatory networks present within this organelle. For example,
in the network specifically shared by CIT-K and its partner
KIF14, we identified the cyclin-dependent kinase 1 (Cdk1) and
the microtubule depolymerizing kinesin KIF2C/MCAK
(Fig. 3c), both also found in the midbody proteome
(Supplementary Data 2 and 4). KIF2C regulates microtubule
dynamics during mitotic spindle assembly19, but it has not
been implicated in cytokinesis. Cdk1, in complex with cyclin B,
is well known to promote mitotic entry and to regulate
multiple mitotic events until anaphase, when most of the
complex is inactivated through degradation of cyclin B.
However, a pool of Cdk1/cyclin B has been described to
accumulate at the midbody where it appears to promote
abscission20. Our data not only indicate a potential role for
KIF2C in cytokinesis and confirm the presence and function of
Cdk1/cyclin B at the midbody, but also suggest that the
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Fig. 1 CIT-K specifically interacts with a multitude of proteins in cytokinesis. aWestern blot analysis of protein extracts from HeLa cells stably expressing a
CIT-K::AcGFP transgene synchronized at different stages of the cell cycle. The blots were probed with antibodies against the proteins indicated to the right.
Numbers on the left indicate the size, in kDa, of the protein ladder. b Proportional Venn diagram showing the number of proteins identified at each cell
cycle stage by AP-MS using CIT-K::AcGFP as bait. cMidbodies purified from HeLa S3 cells treated with siRNAs directed against either a random sequence
(control) or CIT-K were fixed and stained to detect tubulin, CIT-K, and MKLP1. Scale bars, 5 µm. d Logarithmic normalized protein ratios from two
independent SILAC experiments were plotted against each other. Each point represents a single protein identified. Gray dots correspond to proteins that
did not show any significant difference in abundance between control and CIT-K siRNA midbodies. Red and blue dots represent proteins that were either
significantly enriched or less abundant after CIT-K depletion in both biological replicates (p value < 0.01; significance B test corrected by Benjamini-
Hochberg method). e Western blot analysis of total protein extracts and midbodies purified from telophase HeLa S3 cells treated with siRNAs directed
against either a random sequence (control) or CIT-K. The blots were probed with antibodies against the proteins indicated to the right. Numbers on the left
indicate the size, in kDa, of the protein ladder. Source data for Fig. 1a and e are provided as a Source Data file
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association with CIT-K and KIF14 might be important for their
localization and/or function.
PP1β-MYPT1 controls microtubule dynamics in late cytokin-
esis. Cell division is regulated by posttranslational modifications,
including phosphorylation mostly mediated by serine/threonine
kinases and counteracting phosphatases. Although most kinases
involved in cytokinesis are known, the identity and function of
their opposing phosphatases is just emerging4,21. To address this
nescience, we generated a midbody interactome serine/threonine
phosphorylation sub-network by extracting from the entire
interactome dataset proteins whose full names (Uniprot field:
protein names) contained the terms kinase and phosphatase but
excluded those containing tyrosine (Fig. 3d). The most frequent
and abundant phosphatases belong to the PP1 family (Supple-
mentary Table 2), and the top scores include the three PP1 cat-
alytic subunits—α, β, and γ—and the PPP1R12A regulatory
subunit, also known as myosin phosphatase target subunit 1,
MYPT1. PP1γ was described to accumulate at the cleavage site22
and we found that all four PP1 phosphatases localized to the
midbody ring in late cytokinesis, and PP1β and MYPT1 also
accumulated at the cleavage furrow in early telophase (Fig. 4a–d).
The signals detected by these antibodies are specific because they
were strongly reduced after siRNA treatments in both immuno-
fluorescence and western blot analyses (Fig. 4a–e). We then
investigated if siRNA-mediated depletion of these phosphatases
caused cytokinesis failure. siRNA of PP1β and MYPT1 caused the
highest increases in multinucleation (a readout of cytokinesis
failure), 4.2- and 7.2-fold, respectively (Fig. 4g, h). PP1α depletion
did not result in an increase of multinucleated cells and only a
very modest increase (1.6-fold) was observed after PP1γ siRNA
(Fig. 4h). However, combined depletion of these two closely
related catalytic subunits resulted in a 2.8-fold increase in multi-
nucleated cells (Fig. 4h), suggesting that they could act redun-
dantly and/or synergistically in cytokinesis. In sum, our results
indicated that, of all four phosphatases, PP1β and MYPT1 were
the two most strongly required for cytokinesis (Fig. 4e, g, h),
which is consistent with the evidence that MYPT1 is a known
PP1β regulatory subunit23. MYPT1 was reported to antagonize
Plk1 during mitotic spindle assembly and to be required for
cytokinesis24, but its exact role in cytokinesis was not investigated,
probably assuming that it was required to de-phosphorylate the
myosin regulatory light chain (MRLC) at the contractile ring. We
found that, indeed, the levels of both mono(pS19)- and di(pT18
pS19)-phosphorylated MRLC levels were elevated in MYPT1
depleted cells (Fig. 5a, b), which had also an abnormal cytoske-
leton and numerous cortical blebs (Fig. 4f). However, mitotic exit
was not affected after MYPT1 siRNA, as cyclin B levels dropped in
anaphase and dephosphorylation of two phospho-epitopes, PRC1
pT48125 and tri-phospho CHMP4C26,27, known to occur upon
mitotic exit, was not affected (Fig. 5b). MYPT1 siRNA cells could
successfully complete furrowing, although the central spindle
appeared longer and bent upwards in late cytokinesis (Fig. 5a and
Supplementary Movies 1–4). Time-lapse analysis of chromosome
and microtubule dynamics during cell division revealed that
MYPT1 siRNA caused abnormal cortical contractility that did not
prevent furrow formation and ingression, albeit furrowing was
faster than in control cells (Fig. 6a–c, and Supplementary
Movies 5–8), likely because of hyper-phosphorylated MRLC.
Notably, after completion of furrow ingression, MYPT1 siRNA
cells failed to maintain a robust central spindle, which became
very thin, bent and long, and sometime snapped (Fig. 6a–h, and
Supplementary Movie 6). Consistent with these phenotypes, in the
majority of MYPT1 siRNA cells abscission either failed or did not
occur during the period of filming (Fig. 6b and Supplementary
Movie 7). Even when MYPT1 siRNA cells could successfully
separate, abscission was significantly delayed (Fig. 6c). Further-
more, in MYPT1 depleted cells, the midbody was not properly
assembled as many of its components were stretched along the
central spindle and lost their precise arrangement: Aurora B
kinase spread from the midbody arms into the midbody core
(Fig. 6d), the kinesin MKLP1 and the microtubule bundling
protein PRC1 failed to localize as two juxtaposed disks (Figs. 6e–g
and 7a), and CIT-K assembled into misshapen rings that often
collapsed (Fig. 6e, h). Electron microscopy analysis showed that
MYPT1 siRNA midbodies contained fewer microtubules and an
abnormal midbody matrix compared with control cells (Fig. 6i).
These central spindle and midbody defects are not linked to
abnormal cortical contractions or adhesion problems because they
were also observed in less adherent HeLa S3 cells, which do not
form cortical blebs after MYPT1 depletion (Supplementary Fig. 2).
Furthermore, very similar results were obtained in immortalized,
Table 1 Baits used in the AP-MS experiments for the characterization of the midbody interactome
Name Function Localization Tag and cell line
reference
Anillin Actomyosin binding protein; contractile ring scaffolding Cleavage furrow, midbody ring and
secondary constriction sites
GFP48
Aurora B Serine/threonine kinase; CPC component, controls furrow
ingression, central spindle formation and abscission
Cleavage furrow, central spindle,
midbody arms
GFP (this study)
CHMP4B ESCRT-III protein; required for abscission Midbody core and abscission site GFP49
CHMP4C ESCRT-III protein; required for abscission Central spindle, midbody arms, midbody
core and abscission site
Flag26
Citron kinase
(CIT-K)
Serine/threonine kinase; required for midbody assembly,
organization and maturation
Cleavage furrow, central spindle,
midbody ring
AcGFP11
Ect2 Rho GEF; activates RhoA to promote contractile ring
assembly and constriction
Cleavage furrow, central spindle,
midbody core
AcGFP50
KIF14 Kinesin, CIT-K partner; required for midbody assembly,
organization and maturation
Cleavage furrow, central spindle,
midbody ring
GFP51
KIF20A/MKLP2 Kinesin; required for central spindle formation and CPC
translocation
Central spindle, midbody arms GFP51
KIF23/MKLP1 Kinesin; centralspindlin component, required for furrow
ingression, central spindle and midbody formation
Central spindle, midbody core GFP52
PRC1 Microtubule associated protein, required for central spindle
and midbody formation
Central spindle, internal midbody arms
and core
GFP53
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Fig. 2 The midbody proteome and interactome share many proteins and have similar GO enrichment profiles. a Proportional Venn diagram showing the
number of proteins identified in the midbody proteome and interactome. The majority of midbody proteome proteins (62.9%) are contained in the
midbody interactome. b Heat map showing the GO annotation enrichment profiles of the midbody proteome and of the midbody interactome. GO
enrichment profiles were analyzed using PANTHER under the category GO-slim biological process. Overrepresented GO terms are shown in shades of red
while underrepresented GO terms are shown in shades of blue, according to their fold enrichment as indicated in the color scale bar at the right. Only
Bonferroni-corrected results for p < 0.05 were considered (see Supplementary Data 5)
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Fig. 3 The midbody interactome comprises common and specific networks. a Diagram illustrating the entire midbody interactome. Baits are indicated with
blue hexagons, while preys are represented as ovals, either in green, if they were also found in the midbody proteome, or in orange. The edges connecting
the network nodes are colored according to their Mascot scores as indicated in the color scale bar at the top left. Preys shared by multiple baits are
clustered in the center. b Enlargement of the Anillin-specific sub-network shown in the corresponding inset in a. c Enlargement of the baits shared
specifically by CIT-K and KIF4 shown in the corresponding inset in a. d Diagram representing the phosphorylation sub-network. All nodes are labeled with
their primary gene names according to the UniProt database (https://www.uniprot.org)
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12507-9
6 NATURE COMMUNICATIONS |         (2019) 10:4513 | https://doi.org/10.1038/s41467-019-12507-9 | www.nature.com/naturecommunications
non-transformed RPE-1 cells (Supplementary Fig. 3), indicating a
general requirement for MYPT1 in cytokinesis in different cell
types. Finally, almost identical phenotypes were observed after
PP1β siRNA (Fig. 4b and Supplementary Fig. 4), further sup-
porting that MYPT1 is acting as a regulatory subunit for PP1β in
late cytokinesis.
PP1β dephosphorylates the centralspindlin component
MKLP1. Central spindle assembly depends on various micro-
tubule associated proteins (MAPs)2, including two key protein
complexes: centralspindlin, a hetero-tetramer composed of two
MKLP1 and two RacGAP1 subunits, and the PRC1-KIF4A
complex. These MAPs have been shown to interact and cooperate
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to increase the robustness of the central spindle28. To understand
the molecular mechanisms underpinning the phenotypes
observed after MYPT1-PP1β depletion, we investigated whether
centralspindlin could be one of the substrates of this phosphatase.
Centralspindlin clustering at the central spindle midzone is
necessary for its localization and function and requires phos-
phorylation of the evolutionarily conserved MKLP1 S708 residue
by Aurora B29. MYPT1 depletion caused a significant increase in
MKLP1 S708 phosphorylation at the midbody (Fig. 7a, b),
reduced the association of this kinesin with its RacGAP1 partner
and almost completely abolished its interaction with PRC1 and
PP1β, but only mildly affected the association with CIT-K
(Fig. 7c). MKLP1 contains a highly conserved VQF motif 80
amino acids downstream of S708 (aa 786–788; Fig. 7d and Sup-
plementary Fig. 5a) that partially matches the RVxF consensus
binding site for PP1 catalytic subunits30. We found that full
length MKLP1 and PP1β interacted when co-expressed in yeast
(Fig. 7e) and that the MKLP1 C-terminal region (aa 620–858)
purified from bacteria was also able to pull down PP1β in vitro
(Supplementary Fig. 5b-d), indicating that PP1β directly binds to
the MKLP1 C-terminus. MKLP1620–858 was dephosphorylated at
S708 by PP1β in vitro (Fig. 7f, g) and when the VQF residues
were mutated to AQA the binding of MKLP1 to PP1β was
reduced (Fig. 7e and Supplementary Fig. 5b-d) and MKLP1620–858
dephosphorylation by PP1β in vitro was less efficient (Fig. 7f, g).
To assess the role of MKLP1 dephosphorylation by PP1β in vivo,
we generated cell lines stably expressing GFP-tagged versions of
either wild type MKLP1 or of the mutant containing the AQA
mutation at residues 786–788. Silencing MKLP1 by using an
siRNA directed against its 3′UTR that is absent in the GFP-tagged
transgenes severely impaired central spindle assembly and clea-
vage furrow ingression (Fig. 7h, top panels). The very fewMKLP1
siRNA cells that managed to complete furrowing had very thin
central spindles and abnormal PRC1 localization (Fig. 7h),
resembling MYPT1 siRNA cells (Fig. 6). The MKLP1AQA mutant
rescued cytokinesis failure after depletion of endogenous MKLP1
much less efficiently than the wild-type counterpart (Fig. 7h, i).
Importantly, MKLP1AQA could successfully rescue the initial
stages of cytokinesis, but in late telophase central spindles
appeared thin and PRC1 spread along central spindle micro-
tubules (Fig. 7h, bottom panels), again similar to MYPT1 siRNA
cells (Fig. 6). Together, these results indicate that PP1β depho-
sphorylates MKLP1 at S708 in late cytokinesis via association
with the VQF motif and that this dephosphorylation is important
for MKLP1 function in late cytokinesis.
Discussion
Our characterization of the midbody interactome and proteome
represents a significant advance in understanding the complex
and intricate protein–protein interactions of this organelle. Our
interactome is derived from experimental data and provides a
much more realistic and accurate picture than a previous bioin-
formatics study31. The overlap and highly similar GO enrichment
profiles of the interactome and proteome datasets (Fig. 2) strongly
support the validity of our approach and methodology. As
expected, both datasets are enriched in proteins involved in
mitosis and cytokinesis, but they also show a significant enrich-
ment in proteins involved in chromatin assembly and mRNA
processing and translation (Fig. 2 and Supplementary Data 4, 5).
Although unpredicted, these findings are consistent with the
identification of histones at the midbody32 and the evidence that
the RNA-binding protein ATX-2 is involved in posttranscrip-
tional regulation of PAR-5 levels at the midbody33. They also
highlight the possibility that the midbody may function as a
translational hub, which could indicate a mechanism by which
asymmetric inheritance of the midbody imparts genetic infor-
mation in cell fate and carcinogenesis34,35. The identification of
common and specific networks of midbody proteins could serve
to dissect main regulatory mechanisms and pathways for mid-
body function as well as to identify specific roles for each of the
ten baits used in our study. Together, these specific and common
interaction networks will undoubtedly provide an extremely
valuable resource for understanding the emerging multifaceted
biological roles of this organelle. However, our interactome
analysis is limited to one cell type and it is possible that different
proteins and protein–protein interactions exist in midbodies of
different cell types. Nevertheless, our study provides a molecular
blueprint of the interaction networks in the midbody, which can
serve to identify major nodes, hubs and pathways that may
facilitate the analysis and comparison of midbodies in other
cellular and developmental contexts.
The most abundant and frequent phosphatases identified in
our midbody interactome are members of the PP1 family (Fig. 3d
and Supplementary Table 2). This was somehow unexpected as
only PP2A phosphatases had been previously implicated in the
regulation of cytokinesis36,37 and just very recently a role in
abscission was described for PP1γ and its targeting co-factor
RIF138, which was also identified in both our midbody inter-
actome and proteome (Supplementary Data 4). Therefore, our
results expand the repertoire of PP1 functions during mitotic exit
and indicate that MYPT1-PP1β is required to regulate the pace of
cleavage furrow ingression and to form strong and stable central
spindles and midbodies in late cytokinesis (Fig. 6a–c). Cytokinesis
failure after MYPT1 siRNA occurs predominantly at a late stage,
after completion of furrow ingression (Fig. 6b), highlighting an
unanticipated role of MYPT1 in this phase of cell division. Our
results indicate that MYPT1-PP1β regulates the dynamics of the
two major cytokinetic structures, the actomyosin contractile ring
and the central spindle, by de-phosphorylating different
Fig. 4 PP1 phosphatases localize to the midbody and depletion of PP1β and MYPT1 causes cytokinesis failure. a–d HeLa cells were fixed and stained to
detect to detect DNA (blue in the merged panels), tubulin, and PP1α (a), PP1β (b), PP1γ (c), and MYPT1 (d). For RNAi depletions, HeLa cells were treated
with siRNAs directed against each of the three PP1 catalytic subunits or MYPT1 and after 48 h were fixed and stained to detect the same epitopes as
described above. DNA condensation and shape and thickness of microtubule bundles at the intercellular bridge were used as criteria to stage telophase
cells. Insets show a 3× magnification of the midbody. Scale bars, 10 µm. e HeLa Kyoto cells were treated with siRNAs directed against either a random
sequence (control) or each of the three PP1 catalytic subunits (left) or MYPT1 (right) and after 48 h proteins were extracted and analyzed by western blot
to detect the indicated proteins. The numbers on the left indicate the sizes in kDa of the molecular mass marker. f HeLa cells were treated with siRNAs
directed against either a random sequence (control) or MYPT1 and after 48 h were fixed and stained to detect DNA, tubulin, and di-phosphorylated MRLC.
Note that MYPT1 siRNA cells show abnormal cell and nuclear shape, cortical blebs (arrowheads) and disorganized microtubule and actomyosin
cytoskeletal filaments. Scale bars, 10 µm. g HeLa cells were treated with siRNAs directed against either a random sequence (control) or MYPT1 and after
48 h were fixed and stained to detect DNA and tubulin. The arrows indicate multinucleate cells. Scale bars, 10 µm. h Quantification of multinucleate cells
obtained after siRNA of the three PP1 catalytic subunits or MYPT1. More than 500 cells were counted in n≥ 3 independent experiments. Bars indicate
standard errors. *p < 0.05, **p < 0.01 (Mann–Whitney U test). Source data for Fig. 4e and h are provided as a Source Data file
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substrates. In line with its established role, our data indicate that
MYPT1-PP1β dephosphorylates MRLC to control the con-
tractility of the actomyosin ring during furrow ingression (Fig. 5),
but also unexpectedly reveal that MYPT1-PP1β controls the
dynamics of central spindle microtubules in late cytokinesis
(Fig. 6). Our results suggest that the latter could be mediated, at
least in part, through dephosphorylation of MKLP1, and most
likely of other MAPs, in order to antagonize Aurora B and
possibly other mitotic kinases, like Plk1 and CIT-K, in late
cytokinesis (Figs. 6 and 7). We surmise that MKLP1
dephosphorylation by PP1β modulates centralspindlin clustering
in order to promote different functions of this complex in late
cytokinesis, like its close association with other midbody proteins
such as PRC1. This, in combination with dephosphorylation of
additional midbody components, would contribute to MYPT1-
PP1β-mediated regulation of central spindle microtubule
dynamics and midbody architecture in late cytokinesis. In sum,
our findings indicate that temporal changes in the spatial dis-
tribution of kinases and counteracting phosphatases during
cytokinesis control the phosphorylation status, and consequently
M
id
te
lo
ph
as
e
Bo
w
 ti
e 
Ea
rly
te
lo
ph
as
e
Control siRNA MYPT1 siRNA
La
te
te
lo
ph
as
e
M
et
ap
ha
se
Merge MRLC pT18 pS19Tubulin Merge MRLC pT18 pS19Tubulin
a
b
Tubulin
Cyclin B55
55
Min after noc release
Control siRNA MYPT1 siRNA
130 MYPT1
15
15 MRLC pT18 pS19
MRLC pS1915
Pr
om
et
ap
ha
se
La
te
 te
lo
ph
as
e
M
et
ap
ha
se
An
a-
te
lo
ph
as
e
0 45 90 120
PRC1 
PRC1 pT481
Pr
om
et
ap
ha
se
La
te
 te
lo
ph
as
e
M
et
ap
ha
se
An
a-
te
lo
ph
as
e
0 45 90 120
70
70
MRLC
35 CHMP4C pS210 pS214 pS215
Fig. 5 MYPT1 siRNA increases the levels of phosphorylated MRLC, but does not impair furrowing and dephosphorylation during mitotic exit. a HeLa cells
were treated with siRNAs directed against either a random sequence (control) or MYPT1 and after 48 h were fixed and stained to detect DNA (blue in the
merged panels), tubulin, and di-phosphorylated MRLC pT18 pS19. DNA condensation and the shape and thickness of microtubule bundles at the
intercellular bridge were used as criteria to stage telophase cells. Insets show a 3× magnification of the midbody. Scale bars, 10 µm. b Time course analysis
of protein expression and phosphorylation during mitotic exit after MYPT1 depletion. HeLa cells were treated with siRNAs directed against either a random
sequence (control) orMYPT1 and after 24 h synchronized by thymidine/nocodazole block. Cells were collected at the indicate time points after nocodazole
(noc) release and proteins extracted and used in western blot analysis to identify the proteins and phospho-epitopes indicated to the right. The numbers on
the left indicate the sizes of the molecular mass marker. Source data for Fig. 5b are provided as a Source Data file
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12507-9 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:4513 | https://doi.org/10.1038/s41467-019-12507-9 | www.nature.com/naturecommunications 9
the activity, of cytokinesis proteins as illustrated in Fig. 8. In early
telophase MYPT1-PP1β localizes to the cortex of the ingressing
furrow (see Fig. 4) where it can de-phosphorylate MRLC to
antagonize Rho kinase, but has no or little access to the cen-
tralspindlin pool that accumulate at the central spindle midzone,
which is instead highly phosphorylated by Aurora B and can
therefore form clusters. However, after completion of furrow
ingression, MYPT1-PP1β accumulates at the midbody ring
whereas Aurora B is slowly degraded and accumulates at the
midbody arms. This allows dephosphorylation of MKLP1 at S708,
which could strengthen the association of centralspindlin with
other midbody proteins, in particular PRC1. This change in the
phosphorylation status of MKLP1, and most likely of other
midbody components, is important for maintaining a robust
central spindle and for establishing proper midbody architecture.
Finally, our data show that MYPT1 is required for the asso-
ciation of MKLP1 and PP1β in telophase cells (Fig. 7c) and that
PP1β requires the VQF sub-optimal binding motif of MKLP1 to
select its target S708 residue (Fig. 7). However, our current
knowledge of PP1 function indicates that PP1β cannot simulta-
neously interact with both MYPT1 and MKLP1 through their (R)
VxF motifs. One possible explanation could be that MYPT1 is
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necessary to initially bring PP1β in proximity of MKLP1, but then
a pool of PP1β could dissociate from MYPT1 to interact with
MKLP1 through its less efficient VQF site to de-phosphorylate
S708. Future studies can clarify whether such a two-step
mechanism of action does indeed exist and how widely it is
employed by PP1 catalytic subunits.
Methods
Molecular biology. The coding sequence for PP1β was amplified by PCR using the
Addgene plasmid 31677 as a template to create an entry clone in pDONR221 using
Gateway technology according to manufacturer’s instruction (ThermoFisher). The
plasmid pEGFP-C1::MKLP1 was previously described29. The QuikChange Light-
ning Site-Directed Mutagenesis Kit (Agilent) was used to generate the PP1β
phosphatase dead mutant (harboring the mutations D94N and H124N) and the
pEGFP-C1::MKLP1AQA plasmid containing two substitutions in the VQF786–788
binding site for PP1β. The sequence of all DNA constructs were verified by
sequencing (Source BioScience). All oligonucleotides used in this study are listed in
Supplementary Table 3.
Cell culture and treatments. HeLa Kyoto (kind gift from Ina Poser, Max Planck
Institute of Molecular Cell Biology and Genetics) were maintained in DMEM
(Sigma) containing 10% fetal bovine serum (Sigma) and 1% pennicillin/strepto-
mycin (Invitrogen) at 37 °C and 5% CO2. HeLa cell lines stably expressing GFP or
Flag-tagged transgenes (listed in Table S2) were cultured in the same medium with
the addition of appropriate selection antibiotics (puromycin and/or G418). The
HeLa Kyoto cell line stably expressing GFP::tubulin and H2B::mCherry was
described39. hTERT RPE-1 cells (ATCC) were cultured in DMEM/F12 (Sigma)
containing 2 mM L-glutamine, 10% fetal bovine serum (Sigma), and 1% penni-
cillin/streptomycin (Invitrogen) at 37 °C and 5% CO2. HeLa S3 (ATCC) were
culture in DMEM (Sigma) containing 2 mM L-glutamine, 10% fetal bovine serum
(Sigma), and 1% pennicillin/streptomycin (Invitrogen) at 37 °C and 5% CO2.
For RNA interference the following siRNAs were used: scrambled sequence
control: 5′-AACGTACGCGGAATACTTCGA-3′, CIT-K: 5′-ATGGAAGGCACTA
TTTCTCAA-3′, PP1α: 5′-AAGAGACGCTACAACATCAAA-3′, PP1β: 5′-ACGA
GGAUGUCGUCCAGGAA-3′ and 5′-GUUCGAGGCUUAUGUAUCA-3′, PP1γ:
5′-ACAUCGACAGCAUUAUCCAA-3′ and 5′-AGAGGCAGUUGGUCACUCU-
3′, MYPT1: 5′-AGUACUCAACCAUAAUUAA-3′, MKLP1 3′UTR: 5′-AAGCAG
UCUUCCAGGUCAUCUUU-3′, using Lipofectamine RNAiMAX (Invitrogen)
following the manufacturer’s instructions. All these siRNAs have been previously
validated for specificity and efficacy10,24,29,40.
Cell lines stably expressing MKLP1 or MKLP1AQA constructs were generated by
transfecting 2 × 106 HeLa Kyoto cells with 10 μg of plasmid DNA using the Neon
Transfection System (ThermoFisher) using manufacturer’s instructions. After 48 h,
cells in 100 mm culture dish were selected in complete selective medium containing
400 μg ml−1 G418 for ~2 weeks until colonies became visible. Individual colonies
were picked, cultured under resistance and tested for expression of the construct by
western blot and immunofluorescence. To generate the cell line expressing Aurora
B::GFP, HeLa cells (originally from ATCC) were transfected with the mammalian
expression vector pcDNA3.1 containing the coding sequence of human Aurora B,
C-terminally fused to GFP, using FuGENE transfection reagent according to the
manufacturer’s instructions. Twenty-four hours posttransfection G418 was added
to the medium (500 µg ml−1), and cells incubated for a further 7 days. The
population was then expanded and FACS sorted on the GFP signal, and
maintained under G418 selection.
HeLa cells were synchronized in S phase by double thymidine block. Cells
were first arrested in S phase by the addition of 2 mM thymidine (Sigma-
Aldrich) for 19 h, washed twice with phosphate-buffered saline (PBS) and
released for 5 h in fresh complete medium. After release, cells were incubated
again for 19 h in complete medium containing 2 mM thymidine, washed twice
with PBS, released in fresh medium for 10 min, harvested by centrifugation
at 1000 × g for 3 min, washed in PBS, frozen immediately in dry ice and
stored at −80 °C. To synchronize HeLa cells in metaphase and telophase, we
used a thymidine-nocodazole block and release procedure. Cells were first
arrested in S phase by a single thymidine treatment as described above,
washed twice with phosphate-buffered saline (PBS) and released for 5 h in
fresh complete medium. Cells were then cultured for additional 13 h in fresh
complete medium containing 50 ng ml−1 nocodazole (Sigma-Aldrich) and
then harvested by mitotic shake-off. Mitotic cells were washed three times
with PBS, and either released for 30 min in fresh medium containing 10 μM
MG132 (Sigma) to collect cells in metaphase or released in just fresh medium
for 90 min to collect cells in telophase. Cells were then harvested by
centrifugation and frozen in dry ice.
Midbody purification. For SILAC experiments, HeLa S3 cells were grown in
DMEM lacking Arg and Lys (Invitrogen), and supplemented with 10% (v/v) 1 kDa
dialyzed FBS (Sigma-Aldrich), 1% (v/v) penicillin/streptomycin and either unla-
beled Arg and Lys or L-[13C6,15N4] Arg and L-[13C6,15N2] Lys (Cambridge Isotope
Laboratories) at concentrations of 42 μg ml−1 (Arg) and 72 μg ml−1 (Lys). Trypsin-
EDTA was used to split cells as usual. However, as this solution might contain
some non-isotopically labeled amino acids, detached cells were pelleted at 250 × g
for 3 min and washed once with sterile phosphate-buffered saline (PBS) before
being re-seeded in fresh medium.
To purify midbodies, 2.8 × 107 HeLa S3 cells were plated into three three-layer
tissue culture flasks, 525 cm2 (BD Biosciences), for a total of 8.4 × 107 cells per
condition. Cells were synchronized using the thymidine-nocodazole block and
release procedure described in the previous section. After nocodazole washout cells
were incubated for 2 h in fresh medium containing 10 μM MG132 (Sigma-Aldrich)
to further increase the effectiveness of the synchronization, and then incubated at
37 °C for 80 min after release from MG132. Just before collection, 5 μg ml−1 taxol
(Sigma-Aldrich) was added to the medium for 2–3 min to stabilize microtubules
in vivo. Cells were then transferred into a 50 ml conical tube and collected by
centrifugation at 250 × g for 3 min. After one wash with pre-warmed H2O, cells
were gently resuspended in 25 ml of swelling solution (1 mM PIPES pH 7.0, 1 mM
MgCl2, 5 μg ml−1 taxol and Roche Complete Protease Inhibitors) and immediately
centrifuged at 250 × g for 3 min. The cell pellet was then resuspended in 40 ml of
lysis buffer (1 mM PIPES pH 7, 1 mM EGTA, 1% [v/v] NP-40, 5 μg ml−1 taxol, 3 U
ml−1 DNAse I, 10 μg ml−1 RNAse A, 1 Uml−1 micrococcal nuclease, and Roche
Complete Protease Inhibitors) and vortexed vigorously for 1 min. After the
addition of 0.3 volumes of cold 50 mM 2-(N-mopholino)ethanesulfonic acid (MES)
pH 6.3, the sample was incubated on ice for 20 min and then centrifuged at 200 × g
for 10 min at 4 °C. The supernatant was transferred to a new tube and centrifuged
at 650 × g for 20 min at 4 °C to pellet midbodies. The midbody pellet was then
resuspended in 4 ml of 50 mM MES pH 6.3 and centrifuged through a 25 ml
glycerol cushion (40% [w/v] glycerol diluted in 50 mMMES pH 6.3) at 2800 × g for
45 min at 4 °C. After removal of the glycerol cushion, the midbody pellet was
washed with 2 ml of 50 mM MES pH 6.3, transferred to a 15 ml conical tube and
centrifuged at 2800 × g for 20 min at 4 °C. For mass spectrometry (MS) analyses,
after removing as much liquid as possible, the midbody pellet was resuspended in
100 μl of 50 mM MES pH 6.3 and 900 μl of cold acetone were added to the tube,
which was then vortexed and incubated for 10–15 min at −20 °C. The sample was
then centrifuged at 3500 × g for 10 min at 4 °C, the supernatant was carefully
discarded and the pellet was left to dry for 5–10 min at room temperature (RT).
Precipitated proteins were stored at −80 °C until further processing.
Fig. 6 MYPT1 is required for central spindle stability and midbody architecture. a Images from time-lapse recordings of HeLa Kyoto cells expressing GFP::
tubulin and H2B::mCherry treated with control siRNAs or MYPT1 siRNA for 30 h before filming. Time is in min relative to anaphase onset. The arrow in the
90min control cell marks the abscission site, while the arrowhead in the 144min MYPT1 siRNA cell marks the rupture of the central spindle. Scale bar,
10 µm. b Graph showing the frequency of phenotypes observed in the time-lapse recordings described in a. Categories: no abscission indicates cells that
either failed abscission or failed to fully separate during filming (Supplementary Movie 7); early failure indicates cells that failed to form a midbody and
cleavage furrows collapsed (Supplementary Movie 8); broken central spindles indicates cells in which the central spindle broke before abscission occurred,
like in the cell shown in a and in Supplementary Movie 6; n= 59 independent control cells and n= 52 MYPT1 siRNA independent cells were counted.
c Scatter plots showing quantification of furrow ingression (from anaphase onset to furrow completion); n= 57 independent control cells and n= 46
MYPT1 siRNA independent cells were counted. Abscission (from furrow completion to abscission) times measured in the time-lapse recordings described
in a. n= 57 independent control cells and n= 19 MYPT1 siRNA independent cells that successfully completed abscission were counted. Horizontal bars
indicate medians; ****p < 0.0001 (student’s T-test); *p < 0.05 (Mann–Whitney U test). d–h HeLa Kyoto cells (control) or MYPT1 siRNA were stained to
detect the indicated epitopes and DNA. DNA condensation and the size of microtubule bundles at the intercellular bridge were used to stage telophase
cells. Insets show a 3× magnification of the midbody. The arrow in d marks a bend in the central spindle. Scale bars, 10 µm. i Electron micrographs of
midbodies in HeLa cells control or MYPT1 siRNA for 48 h. n= 23 independent control cells and n= 25 MYPT1 siRNA independent cells. The arrowhead
marks an abnormal protrusion of the midbody matrix (MM). Scale bars, 1 µm. Source data for Fig. 6b, c are provided as a Source Data file
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Affinity purification (AP). For large-scale AP of GFP-tagged proteins and asso-
ciated partners, cells were plated at 1/6 confluence in either six 175 cm2 flasks or in
two three-layer 525 cm2 tissue culture flasks (BD Biosciences) and after 24 h
synchronized at different stages of the cell cycle as described in the previous
section, collected, washed in PBS and cell pellets stored at −80 °C. Each cell pellet
was resuspended in 5 ml of lysis buffer (20 mM Tris-HCl, 150 mM NaCl, 2 mM
MgCl2, 1 mM EGTA, 0.1% [v/v] NP-40, 1 mM DTT, 5% [v/v] glycerol and Roche
Complete Protease Inhibitors) and homogenized using a high-performance dis-
perser (Fisher). The homogenate was clarified by centrifugation at 750 × g for
15 min at 4 °C and the supernatant was incubated with 200 μl of GFP-Trap_MA
magnetic beads (ChromoTek) for 4 h on a rotating wheel at 4 °C. Beads were then
washed four times using a magnetic stand in 10 ml of lysis buffer for 5 min on a
rotating wheel at 4 °C, transferred to a new tube and washed one more time in
10 ml of PBS. After removing as much liquid as possible, beads were stored at
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−80 °C before being analyzed by liquid chromatography coupled with tandem MS
(LC-MS/MS; see section below). Most of the AP experiments were carried out in
duplicates, with the exception of CIT-K::AcGFP, which was in triplicate for each
cell cycle phase, and GFP::PRC1, which was performed only once.
Mass spectrometry (MS) analyses. For the analysis of AP samples, beads were
digested with trypsin and processed as previously described10. To analyze SILAC
midbody samples, proteins were resuspended in lysis buffer (100 mM Tris pH 8.5,
100 mM tris[2-carboxyethyl]phosphine, 4% SDS [w/v], 8 M urea) and alkylated by
the addition of iodoacetamide at a final concentration of 40 mM for 30 min at
room temperature in the dark. Samples were then mixed with NuPAGE LDS 4×
Sample Buffer (Invitrogen), boiled for 5 min at 90 °C and loaded on NuPAGE
Novex 4–12% Bis-Tris Protein Gels (Invitrogen). Gels were then fixed for 30 min at
RT in fixing solution (40% [v/v] methanol, 2% [v/v] acetic acid) and stained
overnight with Brilliant Blue G-Colloidal Concentrate (Sigma-Aldrich), according
to the manufacturer’s instructions. Each gel lane was then excised into ~10 bands.
Gel bands were cut into smaller pieces, de-stained completely in 50 mM ammo-
nium bicarbonate/50% (v/v) acetonitrile at 37 °C, and dehydrated in pure acet-
onitrile for 15 min. Gel pieces were then rehydrated in 50 mM ammonium
bicarbonate and digested with Trypsin (Sequencing Grade, Roche) overnight at
37 °C. Peptides were extracted from gel pieces twice for 30 min at 37 °C in 50% (v/
v) acetonitrile/0.5% (v/v) formic acid, dried in a SpeedVac (Thermo Scientific), and
resuspended in 0.5% (v/v) formic acid. For LC-MS/MS analysis of SILAC samples,
an LTQ Orbitrap Velos mass spectrometer (Thermo Scientific) coupled with an
Ultimate 3000 Rapid Separation LC nano ultra high pressure HPLC system
(Dionex) was used. Peptides were loaded and desalted on a PepMap C18 pre-
column (5µ-beads, 100 µm × 20 mm, Dionex) and then separated on a PepMap
analytical column (2 µm beads, 75 µm × 50 cm, Dionex) over a 60 min linear gra-
dient (90 min/cycle) of 4–34% (v/v) acetonitrile/0.1% (v/v) formic acid at a flow
rate of 0.3 μl min−1. The LTQ Orbitrap Velos mass spectrometer was operated in
the top 10 data-dependent acquisition mode where the preview mode was disabled.
The Orbitrap full scan was set at m/z 380–1600 with a resolution of 60,000 at m/z
400. The 10 most abundant multiply charged precursor ions, with a minimal signal
above 2000 counts, were dynamically selected for collision-induced dissociation
fragmentation (MS/MS) in the LTQ Velos ion trap, and the dynamic exclusion was
set ± 20 ppm within 45 s. The AGC and maximum injection time for Orbitrap were
set at 1e6 and 200 ms, and 1e4 and 150 ms for ion trap.
MS data analysis. For protein identification in the SILAC experiments, the raw
files were processed using MaxQuant (version 1.4.0.8) and the Andromeda search
engine41–43. In all cases, peptides were searched against the UniProt human
database concatenated with reversed copies of all sequences and supplemented with
frequently observed contaminants. The following search parameters were used: full
trypsin specificity was required, a maximum of two missed cleavages were allowed,
carbamidomethyl (Cys) was set as a fixed modification, whereas acetylation
(Protein N-term), oxidation (Met), deamidation (Asn/Gln), and carbamylation
(Lys and N-terminus of protein) were considered as variable modifications.
Maximum protein and peptide false discovery rates (FDRs) were set to 1% and
minimum required peptide length was set to seven amino acids. Quantification of
proteins in the SILAC experiment was performed using MaxQuant41. SILAC
multiplicity were set to doublets where Lys0/Arg0 and Lys8/Arg10 were selected as
light and heavy labels, respectively. Peptides considered for quantification were
unique and razor peptides including unmodified, and modified with carbamido-
methylated (Cys), acetylated (Protein N-term), oxidated (Met), carbamylated (Lys
and N-term), and deamidated (Asn/Gln). The re-quantification feature was
enabled. Statistical evaluation of MS results generated by MaxQuant was performed
using Perseus41.
For the identification of proteins from AP experiments, raw MS/MS data were
analyzed using the MASCOT search engine (Matrix Science). Peptides were
searched against the UniProt human sequence database and the following search
parameters were employed: enzyme specificity was set to trypsin, a maximum of
two missed cleavages were allowed, carbamidomethylation (Cys) was set as a fixed
modification, whereas oxidation (Met), phosphorylation (Ser, Thr and Tyr), and
ubiquitylation (Lys) were considered as variable modifications. Peptide and MS/MS
tolerances were set to 25 parts per million (ppm) and 0.8 daltons (Da). Peptides
with MASCOT Score exceeding the threshold value corresponding to < 5% false
positive rate, calculated by MASCOT procedure, and with the MASCOT score
above 30 were considered to be positive.
Computational and statistical analyses. We used in-house written Perl scripts to
combine the Mascot data from the replicates of AP-MS experiments for each bait
and to compare them with datasets obtained from AP-MS experiments using HeLa
cells expressing GFP alone at the same cell cycle stage (S phase, metaphase, or
telophase) in order to eliminate non-specific hits. Prey hits absent from these GFP
negative controls were classed as being specific. Additional common contaminants,
such as keratins and hemoglobin, were eliminated manually. The filtered data
(Supplementary Data 3) were then analyzed and visualized using Cytoscape (ver-
sion 3.7.0).
To generate the serine/threonine phosphorylation sub-network, we searched the
interactome dataset for proteins whose Uniprot protein names field contained the
terms kinase and phosphatase but not tyrosine via grep in the Unix command line.
This generated a dataset of 190 proteins that was subsequently manually curated to
eliminate proteins that were not directly involved in phosphorylation/
dephosphorylation, such as kinase-associated proteins for example. The final list of
136 proteins was entered into a raw tab-delimited text file and then imported into
Cytoscape to generate the network shown in Fig. 3d.
GO enrichment analysis was performed using PANTHER44. Prism8
(GraphPad) and Excel (Microsoft) were used for statistical analyses and to prepare
graphs.
Time-lapse imaging. For time-lapse experiments, HeLa Kyoto cells expressing
GFP:tubulin and H2B::mCherry were plated on an open µ-Slide with 8 wells (Ibidi,
80826) 30 h after RNAi treatment. Imaging was performed on a Leica DMi8 CS
AFC Motorised Research Inverted Digital Microscope. Images were collected with
a 40 × /1.30 NA HC Plan APO CS2 - OIL DIC 240 μm objective and excitation
Lasers of Argon (65 mW, 488 nm) and of DPSS (20 mW, 561 nm). We used the
Application Suite X software (LAS-X; Leica) for multidimensional image acquisi-
tion. Specimens were maintained at 37 °C and 5% CO2 via a chamber, and z-series
of 14, 1-µm sections were captured at 2 min intervals. All images were processed
using Fiji45 to generate maximum intensity projections, to adjust for brightness and
contrast, and to create the final movies.
Fluorescence microscopy. HeLa cells were grown on microscope glass coverslips
(Menzel-Gläser) and fixed in either PHEM buffer (60 mM Pipes, 25 mM Hepes pH
7, 10 mM EGTA, 4 mM MgCl2, 3.7% [v/v] formaldheyde) for 12 min at room
temperature or in ice-cold methanol for 10 min at −20 °C. They were then washed
three times for 10 min with PBS and incubated in blocking buffer (PBS, 0.5% [v/v]
Triton X-100 and 5% [w/v] BSA) for 1 h at room temperature. Coverslips were
incubated overnight at 4 °C with the primary antibodies indicated in the figure
legends, diluted in PBT (PBS, 0.1% [v/v] Triton X-100 and 1% [w/v] BSA). The day
after, coverslips were washed twice for 5 min in PBT, incubated with secondary
antibodies diluted in PBT for 2 h at RT and then washed twice with PBT and once
with PBS. Coverslips were mounted on SuperFrost Microscope Slides (VWR) using
VECTASHIELD Mounting Medium containing DAPI (Vector Laboratories).
Phenotypes were blindly scored by at least two people independently. Images were
Fig. 7 PP1β dephosphorylates MKLP1 at S708 in cytokinesis. a HeLa Kyoto cells were treated with control orMYPT1siRNA for 48 h and stained to detect the
indicated epitopes. Cells were staged as in Fig. 4. Insets indicate 3× magnification of the midbody. Scale bars, 10 µm. b Quantification of total and pS708
MKLP1 in control and MYPT1siRNA cells. The boxes indicate the first quartile to the third quartile, the horizontal lines the median and the whiskers the
minimum or maximum. AU, arbitrary unit; n= 32 independent control cells and n= 35 MYPT1 siRNA independent cells for MKLP1 stained cells; n= 38
independent control cells and n= 42 MYPT1 siRNA independent cells for MKLP1-pS708 stained cells; p values from student’s T-test. c HeLa stably
expressing GFP-MKLP1 were treated with control orMYPT1 siRNA, synchronized in telophase and GFP pull-down protein extracts analyzed by western blot.
The numbers indicate the sizes of the molecular mass marker. d Schematic diagram of MKLP1 protein. The Aurora B phosphorylation site and the VQF PP1-
binding site are indicated. eMBP-tagged MKLP1, MKLP1AQA or MBP alone were co-expressed in yeast and used for MBP pull-down assay. Extracts and pull
downs were analyzed by western blot to detect GST and MBP. Numbers indicate the size of the protein ladder. f In vitro phosphatase assay of GST-tagged
WT and AQA MKLP1. The reactions were incubated with either MBP-tagged PP1β or a catalytically dead version for the times indicated at the top and
analyzed by western blot using antibodies against MKLP1 pS708 and GST. g Graph showing the normalization of MKLP1 pS708 values against the amounts
of GST-MKLP1620–858. h HeLa Kyoto cells stably expressing GFP-MKLP1, GFP-MKLP1AQA or no transgene were treated with either control or MKLP1 3′UTR
siRNA were stained to detect the indicated epitopes. Scale bars, 10 µm. i Quantification of multinucleate cells from the experiments shown in h. More than
500 independent cells were counted in n≥ 3 independent experiments. Bars indicate standard errors. *p < 0.05, **p < 0.01, ***p < 0.001 (Mann–Whitney U
test). Source data for Fig. 1b-c, e–g and i are provided as a Source Data file
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acquired using a Zeiss Axiovert epifluorescence microscope equipped with Meta-
Morph software. Fiji45 was used to generate maximum intensity projections, which
were adjusted for contrast and brightness and assembled using Photoshop.
Fluorescence intensity values in Fig. 7b were measured from identically sized areas
at the midbody (IM), in the nucleus (IN), and in the background (IB) using Fiji45
and then normalized values were calculated using the following formula: [(IM−IB)
−(IN−IB)]/(IN−IB)= (IM−IN)/(IN−IB).
Antibodies. The following antibodies and dilutions for western blot (WB) and
immunofluorescence (IF) were used in this study: mouse monoclonal anti α-
tubulin (clone DM1A, Sigma, T9026 dilutions for WB 1:20,000, for IF 1:2000),
rabbit polyclonal anti-β-tubulin (Abcam, ab6046 dilutions for WB 1:5000, for IF
1:400), mouse monoclonal anti-cyclin B1 (clone GNS1, Santa Cruz, sc-245 dilution
for WB 1:2000), mouse monoclonal anti-PP1α (clone G-4, Santa Cruz, sc-271762
dilutions for WB 1:1000, for IF 1:50), mouse monoclonal anti-PP1β (clone A-6,
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Fig. 8 Model of regulation of centralspindlin by Aurora B and MYPT1-PP1β during cytokinesis. During furrowing (top panel) MYPT1-PP1β accumulates at the
cortex with no or very limited access to the centralspindlin pool that localizes to the central spindle midzone, which is highly phosphorylated by Aurora B and
therefore can form clusters. After completion of furrow ingression, MYPT1/PP1β accumulates at the midbody ring whereas Aurora B localizes to the midbody
arms (bottom panel). This allows PP1β to de-phosphorylate MKLP1 at S708, which could strengthen the association of centralspindlin with PRC1. See text for
more details
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Santa Cruz, sc-365678 dilutions for WB 1:10,000, for IF 1:50), mouse monoclonal
anti-PP1γ (clone A-4, Santa Cruz, sc-515943 dilutions for WB 1:2000, for IF 1:50),
mouse monoclonal anti-CIT-K (BD Transduction Laboratories, 611377 dilutions
for WB 1:1500, for IF 1:250), mouse monoclonal anti-MYPT1 (clone C-6, Santa
Cruz, sc-514261 dilutions for WB 1:1500, for IF 1:50), rabbit polyclonal anti-
Aurora A (Abcam, ab1287 dilution for WB 1:4000), rabbit polyclonal anti-TPX2
(Novus Biologicals, NB500-179 dilution for WB 1:1000), rabbit polyclonal anti-
KIF14 (Bethyl Laboratories A300-233A dilution for WB 1:2000) rabbit polyclonal
anti-MKLP1 (clone N19, Santa Cruz Biotechnology, sc-867, dilutions for WB
1:3000, for IF 1:500), rabbit polyclonal anti-phospho MKLP1 pS70829 (dilutions for
WB 1:2000, for IF 1:200), rabbit polyclonal anti-tri-phospho CHMP4C pS210
pS214 pS21527 (dilution for WB 1:400), mouse monoclonal anti-Aurora B (clone
AIM-1, BD Transduction Laboratories, 611082 dilutions for WB 1:2000, for IF
1:100), mouse monoclonal anti-PRC1 (clone C-1, Santa Cruz, sc-376983 dilutions
for WB 1:5000, for IF 1:100), rabbit monoclonal anti-phospho PRC1 pT481
(Abcam, ab62366 dilution for WB 1:12,000), rabbit polyclonal anti-phospho-
histone H3 pS10 (Merck, 06-570 dilution for WB 1:10,000), rabbit polyclonal anti-
mono-phospho MRLC pS19 (Cell Signaling Technology, 3671, dilutions for WB
1:1000, for IF 1:50), rabbit polyclonal anti-di-phospho MRLC pT18 pS19 (Cell
Signaling Technology, 3674, dilutions for WB 1:1000, for IF 1:100), goat polyclonal
anti-RacGAP1 (Abcam, ab2270 dilution for WB 1:1000), mouse monoclonal anti-
GST (Abcam, ab92 dilution for WB 1:20,000), mouse monoclonal anti-MBP (NEB,
E8032 dilution for WB 1:10,000). Peroxidase and Alexa-fluor conjugated secondary
antibodies were purchased from Jackson Laboratories and ThermoFisher,
respectively.
Transmission electron microscopy. For electron microscopy analyses, HeLa
Kyoto cells were plated on microscope glass coverslips (Menzel-Gläser). Cells were
fixed overnight at 4 °C in 2.5% [v/v] glutaraldehyde in PBS, post fixed for 1 h in 1%
[v/v] OsO4 in PBS, dehydrated in a graded series of alcohols, embedded in Epon-
Araldite resin, and polymerized for 2 days at 60 °C. Glass slides were separated
from the resin after a short immersion in liquid nitrogen. Sections were obtained
with a LKB ultratome, stained with uranyl acetate and lead citrate, and observed
and photographed with a FEI Tecnai G2 Spirit transmission electron microscope
operating at an accelerating voltage of 100 kV and equipped with a Morada CCD
camera (Olympus).
Protein expression time course and GFP pull-down assay. 1.4 × 106 HeLa Kyoto
cells were plated in large—175 cm2—flasks and transfect with siRNAs (800 pmol)
directed against either a scrambled sequence (control) or MYPT1. After 24 h, cells
were synchronized by thymidine/nocodazole block, released in fresh medium and
divided into four 75 cm2 flasks, and collected after 0, 45, 90, and 120 min as
indicated in Fig. 7. Proteins were then extracted, separated on a SDS-PAGE gel,
transferred onto PVDF membrane, and probed to detect the antigens indicated in
Fig. 7. Uncropped versions of all blots can be found in the Source Data file.
For GFP pull-down assay, GFP::MKLP1 HeLa cells were transfected with
siRNAs and synchronized in late telophase (120 min after nocodazole release) as
described above. Cells were then collected, washed in PBS, frozen in dry ice and
stored at −80 °C. Cell pellets were resuspended in 0.5 ml of lysis buffer (20 mM
Tris-HCl, 150 mM NaCl, 2 mM MgCl2, 1 mM EGTA, 0.1% [v/v] NP-40, 1 mM
DTT, 5% [v/v] glycerol, Roche Complete Protease Inhibitors and PhosSTOP
Protein Phosphatase Inhibitors) and homogenized using a high-performance
disperser (Fisher). The homogenate was clarified by centrifugation at 750 × g for
15 min at 4 °C and the supernatant was incubated with 40 μl of GFP-Trap MA
magnetic Beads (ChromoTek) for 4 h on a rotating wheel at 4 °C. Beads were then
washed four times in 1 ml of lysis buffer for 5 min on a rotating wheel at 4 °C,
transferred to a new tube and washed one more time in 1 ml of PBS. After
removing as much liquid as possible, beads were resuspended in 2× Laemmli
sample buffer (Sigma-Aldrich), boiled for 5 min and stored at −20 °C. Proteins
were separated by SDS-PAGE, transferred onto PVDF membrane, and probed to
detect the antigens indicated in Fig. 7c. Uncropped versions of all blots can be
found in the Source Data file.
Protein purification and binding assays in yeast. Interaction between MBP-
MKLP1 and GST-PP1β was explored in S. cerevisiae using a modification of the
method described46. Briefly, MBP-MKLP1 proteins (wild-type and AQA mutant)
were expressed using a derivative of plasmid pMH919 carrying MBP instead of 6His
and GST-PP1β using pMH925. Wild type and mutant alleles were amplified by PCR
with oligos containing at their 5′ 40 bps homologous to pMH919 and pMH925,
respectively. All expressing plasmids were obtained by recombination (GAP repair)47
using strains MGY140 for the MKLP1 constructs and MGY139 [Mat a, ade5, ura3-5,
trp1-289, his3, leu2, lys2Δ0, mob1::kanMX4, cdc28::LEU2, pep4::LYS2/YCplac33-
MOB1-CDC28] for the PP1β construct. After recombination, strains were crossed
and passed on FOA plates to obtain diploid strains stably expressing pairs of MKLP1
and PP1β proteins (see below). For expression and purification, strains were cultivated
for 6 h in YPGal to induce the expression of the recombinant proteins. Cell pellets
were resuspended in Breaking Buffer (50mM Tris-HCl pH 7.5, 250mM NaCl, 10%
glycerol, 0.2% [v/v] NP-40, 5mM EDTA, 5mM DTT, Protease Inhibitor cocktail and
1mM PMFS) and crude extract was obtained by vortexing in presence of glass beads
(0.5mm diameter). MBP-MKLP1 proteins were purified on amylose resin (New
England Biolabs), washed five times with Washing Buffer (50mM Tris-HCl pH 7.5,
250mM NaCl, 0.2% [v/v] NP-40, 5 mM DTT) and eluted with 20mM maltose. The
presence of GST-PP1β bound to MKLP1 was revealed by western blotting using an
anti-GST antibody. Uncropped versions of all blots can be found in the Source Data
file.
PP1β and PP1βdead proteins were expressed and purified as MBP-fusion
proteins in S. cerevisiae essentially as described above. Briefly, MBP-PP1β proteins
were expressed using a derivative of plasmid pMH919 carrying MBP instead of
6His. PP1β and PP1βdead coding sequences were amplified by PCR with
oligonucleotides containing at their 5′ 40 bps homologous to pMH919. Expressing
plasmids were obtained by recombination using strain MGY70 (see below). For
expression and purification, strains were cultivated for 6 h in YPGal to induce the
expression of the recombinant proteins. Cell pellets were resuspended in Breaking
Buffer and crude extract was obtained by vortexing in presence of glass beads (0.5
mm diameter). MBP-PP1β proteins were purified on amylose resin and eluted with
20 mM maltose as described above. These are the S. cerevisiae strains generated
during this study: MGY930, to express MBP/GST-PP1β; MGY931 to express MBP-
MKLP1 and GST; MGY932 to express MBP-MKLP1 and GST-PP1β; MGY951 to
express MBP-MKLP1AQA and GST-PP1β; MGY960 to express MBP-PP1β; and
MGY961 to express MBP-PP1βdead.
In vitro GST pull-down and phosphatase assays. DNA fragments coding for
MKLP1620–858 (wild type and AQA mutant) were generated by PCR and cloned
into pDEST15 (ThermoFisher) to express N-terminal GST-tagged polypeptides in
E. coli. GST-tagged products were then purified using Glutathione Sepharose 4B
according to manufacturer’s instruction (GE Healthcare).
For GST pull downs, MBP::PP1β purified from yeast and eluted from beads (see
previous section) was mixed with 25 μl of Glutathione Sepharose beads containing
purified GST or GST::MKLP1620–858 proteins (wild type and AQA mutant).
Samples were incubated in 300 μl of NET-N+ buffer (50 mM Tris-HCl, pH 7.4,
150 mM NaCl, 5 mM EDTA, 0.2% NP-40, and a cocktail of Roche Complete
Protease Inhibitors) for 60 min at 4 °C on a rotating wheel and then washed five
times with 500 μl of wash buffer (50 mM Tris-HCl, pH 7.4, 250 mM NaCl, 5 mM
EDTA, 0.2% NP-40, and a cocktail of Roche Complete Protease Inhibitors)
followed by centrifugation at 500 × g for 1 min. Beads were resuspended in 25 μl of
Laemmli SDS-PAGE sample buffer and typically 1/5 was loaded on a 4–20% Tris-
Glycine gel for western blot analysis. Uncropped versions of all blots can be found
in the Source Data file.
For the phosphatase assay, 10 μg of purified GST-MKLP1620–858 proteins (wild-
type and AQA mutant) bound to beads were phosphorylated in vitro with 2 μg of
recombinant His-tagged Aurora B (ThermoFisher) in 40 μl final volume of kinase
buffer (20 mM HEPES pH 7.5, 5 mM MgCl2, 1 mM DTT, 0.1 mM cold ATP) at
30 °C for 30 min and then washed three times with 500 μl of phosphatase buffer
(50 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM MnCl2) to remove His-tagged
Aurora B. Beads were then resuspended in 100 μl of phosphatase buffer, divided in
10 aliquots, and each aliquot was incubated with 200 ng of either MBP-PP1β or
MBP-PP1βdead enzymes purified from yeast (see previous section) at 30 °C with
gentle agitation. Samples were collected at 10, 20, 40, and 60 min and reactions
were immediately stopped with the addition of 2× Laemmli buffer. Proteins were
separated by SDS-PAGE and analyzed by western blot with anti-phospho MKLP1
pS708 and anti-GST antibodies. Uncropped versions of all blots can be found in the
Source Data file. Chemiluminescent signals were acquired below saturation levels
using a G:BOX Chemi XRQ (Syngene) and quantified using Fiji45.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The SILAC mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner repository with the dataset
identifier PXD012374. The other proteomics data supporting the findings of this study
are available within the paper and its supplementary information. All other data,
materials and reagents are available from the corresponding author upon reasonable
request. The source data underlying Figs. 1a, 1e, 4e, 4h, 5b, 6b, c, 7b, c, 7e–g, 7i, and
Supplementary Figs. 1, 3a, 3c and 5c are provided as a Source Data file.
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